What is the OncoNext study?
OncoNext is a genetic test designed to detect hereditary mutations associated with cancer predisposition. The test includes an examination of key genes linked to various types of hereditary cancer, such as breast, ovarian, colon, prostate cancer, and others. The test offers the possibility of early detection of genetic risks, enabling preventive measures and a personalized monitoring plan.
Why should we get tested?
Genetic research, like OncoNext, is key to identifying an individual's risk of developing hereditary forms of cancer. These tests allow for the adoption of preventative measures and the avoidance of potentially harmful factors that can increase the risk of developing cancer. Early detection and monitoring are essential for timely diagnosis and effective treatment, which significantly improves prognosis and quality of life.
What do we offer?
OncoNext offers comprehensive genetic analysis, including DNA sequencing to identify mutations in genes associated with hereditary cancer syndromes. The test is fast, accurate, and accessible, with results available within 15 business days. Each client receives a free consultation with a genetic expert for interpretation of results and recommendations for next steps.
Who should be examined?
OncoNext is recommended for individuals with a family history of cancer, especially in cases of breast, ovarian, colon, or other forms of cancer within the family. People who have developed cancer before the age of 50 or who have multiple relatives with cancer are also potential candidates for the test.
OncoNext provides information on tumor characteristics, treatment options, and clinical trials.
OncoNext provides detailed information about an individual's genetic profile, identifying specific mutations that may increase the risk of developing cancer. This information is valuable for physicians in determining a personalized plan for prevention, monitoring, and treatment.
For more information and details regarding the test, you can call tel. ☎️ 0878 500 730
